Cargando…

Epidemiological impact and cost‐effectiveness of providing long‐acting pre‐exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study

INTRODUCTION: Although pre‐exposure prophylaxis (PrEP.) is an efficacious HIV prevention strategy, its preventive benefit has not been shown among young women in sub‐Saharan Africa, likely due to non‐adherence. Adherence may be improved with the use of injectable long‐acting PrEP methods currently b...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Vliet, Marjolein M, Hendrickson, Cheryl, Nichols, Brooke E, Boucher, Charles AB, Peters, Remco PH, van de Vijver, David AMC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6922023/ https://www.ncbi.nlm.nih.gov/pubmed/31855323 http://dx.doi.org/10.1002/jia2.25427

Ejemplares similares

Pre-treatment HIV drug resistance testing cost-effectiveness
por: van de Vijver, David AMC, et al.
Publicado: (2020)

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C
por: Popping, Stephanie, et al.
Publicado: (2018)

Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study
por: Nichols, Brooke E, et al.
Publicado: (2014)

Quality of life among people living with HIV in England and the Netherlands: a population-based study
por: Popping, Stephanie, et al.
Publicado: (2021)

Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa
por: Noguchi, Lisa M., et al.
Publicado: (2021)

Letter to the editor: Pre-exposure prophylaxis for HIV in Europe: The need for resistance surveillance
por: van Tienen, Carla, et al.
Publicado: (2017)

Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
por: Bakshi, Rahul P., et al.
Publicado: (2018)

Doxycycline post-exposure prophylaxis for sexually transmitted infections in South Africa
por: Peters, Remco P.H., et al.
Publicado: (2023)

Long-Acting Injectable Drugs for HIV-1 Pre-Exposure Prophylaxis: Considerations for Africa
por: Moyo, Enos, et al.
Publicado: (2022)

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
por: van de Vijver, David A M C, et al.
Publicado: (2019)

Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study
por: Nichols, Brooke E., et al.
Publicado: (2013)

Safety and efficacy of long-acting injectable cabotegravir as preexposure prophylaxis to prevent HIV acquisition
por: Fonner, Virginia A., et al.
Publicado: (2023)

Trends and factors influencing long-acting contraceptive utilisation among contraceptive users in Ethiopia: repeated cross-sectional study
por: Tadele, Afework, et al.
Publicado: (2021)

Relative cost-effectiveness of long-acting injectable cabotegravir versus oral pre-exposure prophylaxis in South Africa based on the HPTN 083 and HPTN 084 trials: a modelled economic evaluation and threshold analysis
por: Jamieson, Lise, et al.
Publicado: (2022)

The effect of joint contraceptive decisions on the use of Injectables, Long-Acting and Permanent Methods (ILAPMs) among married female (15–49) contraceptive users in Zambia: a cross-sectional study
por: Mutombo, Namuunda, et al.
Publicado: (2014)

Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-saving
por: Popping, Stephanie, et al.
Publicado: (2019)

Provider perspectives on contraceptive service delivery: findings from a qualitative study in Johannesburg, South Africa
por: Lince-Deroche, Naomi, et al.
Publicado: (2020)

Long-Acting Reversible Contraception
por: Machado, Rogerio Bonassi, et al.
Publicado: (2017)

Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa
por: Cheng, Chih-Yuan, et al.
Publicado: (2019)

Sources of Contraceptive Commodities for Users in Nigeria
por: Oye-Adeniran, Boniface A, et al.
Publicado: (2005)

One-year discontinuation among users of the contraceptive pill and injection in South East Tigray region, Ethiopia
por: Gebrslasie, Kahsay Zenebe, et al.
Publicado: (2023)

Injectable long acting antiretroviral for HIV treatment and prevention: perspectives of potential users
por: Slama, Laurence, et al.
Publicado: (2023)

Long acting reversible contraceptive utilization and its associated factors among modern contraceptive users in high fertility sub-Saharan Africa countries: a multi-level analysis of recent demographic and health surveys
por: Negash, Wubshet Debebe, et al.
Publicado: (2022)

Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia
por: Bereku, Tessema, et al.
Publicado: (2022)

Policy and programmatic considerations for introducing a longer-acting injectable contraceptive: perspectives of stakeholders from Kenya and Rwanda
por: McKenna, Kevin, et al.
Publicado: (2014)

Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives
por: Harryparsad, Rushil, et al.
Publicado: (2023)

Systematic Review of the profile of emergency contraception users
por: Amengual, Maria de Lluc Bauzà, et al.
Publicado: (2016)

A comparative study on attitude of contraceptive methods users towards common contraceptive methods
por: Ehsanpour, Soheila, et al.
Publicado: (2010)

Effects of immediate postpartum contraceptive counseling on long-acting reversible contraceptive use in adolescents
por: Kaewkiattikun, Kasemsis
Publicado: (2017)

Potential user interest in new long-acting contraceptives: Results from a mixed methods study in Burkina Faso and Uganda
por: Callahan, Rebecca L., et al.
Publicado: (2019)

RISUG: An intravasal injectable male contraceptive
por: Lohiya, N.K., et al.
Publicado: (2014)

A better future for injectable contraception?
Publicado: (2014)

The Coming-of-Age of Subcutaneous Injectable Contraception
por: Cole, Kimberly, et al.
Publicado: (2018)

Seroprevalence of HIV, hepatitis b, and hepatitis c among opioid drug users on methadone treatment in the netherlands
por: Schreuder, Imke, et al.
Publicado: (2010)

Which contraceptive side effects matter most? Evidence from current and past users of injectables and implants in Western Kenya
por: Odwe, George, et al.
Publicado: (2020)

Preferences for a potential longer-acting injectable contraceptive: perspectives from women, providers, and policy makers in Kenya and Rwanda
por: Tolley, Elizabeth E, et al.
Publicado: (2014)

Long-Acting Injectable Cabotegravir for HIV Preexposure Prophylaxis Among Sexual and Gender Minorities: Protocol for an Implementation Study
por: Grinsztejn, Beatriz, et al.
Publicado: (2023)

Effect of the Monthly Injectable Combined Contraceptives versus Oral Contraceptive Pills on Mood
por: Khafagy, Ghada M., et al.
Publicado: (2021)

Partner Notification for Reduction of HIV-1 Transmission and Related Costs among Men Who Have Sex with Men: A Mathematical Modeling Study
por: Nichols, Brooke E., et al.
Publicado: (2015)

Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon
por: Ajong, Atem Bethel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mr3hlrpm5tpq9ciqdeotpq36nt